Press Releases

Date Title and Summary Additional Formats
Toggle Summary Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress
Fluidigm Posts Sequential and Year-Over-Year Quarterly Revenue Growth 2017 Highlights Include Launch of Hyperion Imaging System, Licensing and Distribution Partnerships, Improved Balance Sheet, Double-Digit Operating Expense Reductions Mass Cytometry Research Publications Increase by More than 40%
View HTML
Toggle Summary Fluidigm to Report Q4 and Full Year 2017 Financial Results
SOUTH SAN FRANCISCO, Calif. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report fourth quarter and full year 2017 financial results on Thursday, February 8, 2018 , after the financial markets close.
View HTML
Toggle Summary Fluidigm Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. , Dec. 21, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent directors, granted an equity award on December 15, 2017 , under Fluidigm's 2017
View HTML
Toggle Summary Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference
SOUTH SAN FRANCISCO, Calif. , Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite , President and CEO, and Vikram Jog , Chief Financial Officer, will participate in the upcoming 29th Annual Piper Jaffray Healthcare Conference in New York, NY .
View HTML
Toggle Summary Fluidigm Announces Third Quarter Financial Results and Operational Progress
SOUTH SAN FRANCISCO, Calif. , Nov. 02, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the third quarter ended September 30, 2017 . Total revenue for the third quarter was $24.7 million , an increase of 12% from $22.2 million in the third quarter of
View HTML
Toggle Summary Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis
Fluidigm to distribute histoCAT™, the first multiparameter Imaging Mass Cytometry™ software that combines leading-edge image and cytometry analysis tailored to highly multiplexed imaging data in a simple and easy-to-use format.
View HTML
Toggle Summary Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues
The Hyperion™ Imaging System provides translational researchers with an unprecedented view of complex cellular phenotypes and their relationships in the tissue microenvironment.
View HTML
Toggle Summary Fluidigm to Report Q3 2017 Financial Results and Host Conference Call
SOUTH SAN FRANCISCO, Calif. , Oct. 19, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report third quarter 2017 financial results on Thursday, November 2, 2017 , after the financial markets close. Chris Linthwaite , President and CEO, and Vikram Jog , Chief
View HTML
Toggle Summary Fluidigm to Unveil High-Parameter Tissue Imaging System
SOUTH SAN FRANCISCO, Calif. , Oct. 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue imaging on Tuesday, October 24, 2017 , via a global livestream video.
View HTML
Toggle Summary Fluidigm to Participate in Two Upcoming Health Care Conferences in September
SOUTH SAN FRANCISCO, Calif. , Aug. 28, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite , President and CEO, and Vikram Jog , Chief Financial Officer, will participate in two upcoming health care conferences in New York, NY .
View HTML